-transparent.png){kind=logo}
Fourteen patients with classical or definite rheumatoid arthritis were studied for the effect of piroxicam treatment on clinical parameters and cellular immunity. The treatment caused reduced disease activity as assayed by an augmented grip strength, reduced total stiffness, reduced duration of morning stiffness and reduced Ritchies articular index. No effect of the treatment was observed on the percentages of T8 and T4 positive cells nor on the natural killer (NK) cell activity in the peripheral blood mononuclear cells. In contrast, the treatment led to a reduction in the total amount of rheumatoid factor. Since rheumatoid factor is mainly produced locally in the inflamed synovial membranes, our results suggest an effect of piroxicam on the immune system locally but not in the peripheral blood.
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
November 1984,
Lancet (London, England),
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
March 1984,
British journal of clinical pharmacology,
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
October 1993,
Acta paediatrica Japonica : Overseas edition,
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
January 1991,
European journal of rheumatology and inflammation,
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
May 1987,
Nihon rinsho. Japanese journal of clinical medicine,
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
September 1980,
British medical journal,
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
January 1982,
Clinical pharmacokinetics,
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
June 1993,
British journal of rheumatology,
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
July 1978,
The Medical journal of Australia,
O Førre, and
J Thoen, and
K Helgetveit, and
Y Haile
March 1992,
Nihon rinsho. Japanese journal of clinical medicine,
